The Findings That Surprised Me: Three DEA Inspections, One Pharmacy LeaderThe Findings That Surprised Me: Three DEA Inspections, One Pharmacy Leader
Drug Diversion Insights with Terri Vidals
Pharmacist Brennan Luke shares what he experienced during three DEA inspections and how those visits reshaped his approach to drug diversion prevention. The conversation looks at regulatory details, culture change and practical first steps for healthcare leaders who want safer controlled substance practices.
41:19•1 Jul 2026
Three DEA Inspections and the Pharmacy Leader Who Learned From Them
Episode Overview
- DEA inspections focus heavily on accountability audits, documentation accuracy and security, rather than just post-dispense monitoring.
- Even well-intentioned practices can be out of regulation, so leaders need a detailed understanding of DEA rules and the pharmacist manual.
- Hospitals often overinvest in detecting diversion events and underinvest in foundational compliance and prevention work.
- De-stigmatising diversion and substance use disorder helps colleagues speak up earlier and supports staff in getting help sooner.
- For organisations with weak programmes, starting with a gap assessment, basic procurement and inventory checks, and clear reporting expectations is key.
“I would rather have that uncomfortable conversation than go to their funeral.”
What can hospital leaders learn from three separate DEA inspections? This conversation between host Terri Vidals and pharmacist Brennan Luke gives healthcare professionals a front-row seat to exactly that. Aimed at people working in hospitals and health systems who worry about drug diversion but might not know where to start, the episode breaks down what DEA inspectors really look for and why “doing a good job” isn’t the same as being compliant.
Brennan, now Regulatory and Controlled Substance Pharmacy Manager at ECU Health, shares how he built a diversion prevention programme across multiple hospitals and then watched it tested by routine DEA visits. You’ll hear him explain how the agents arrived “very unassuming” and focused on accountability audits, cradle‑to‑grave tracking of selected controlled substances, and meticulous record‑keeping.
Brennan talks about colleagues with substance use disorder, including a nurse whose diversion, arrest and later suicide still shape how he approaches prevention and early intervention: “I would rather have that uncomfortable conversation than go to their funeral.” Terri steers the chat toward practical advice for leaders with little or no programme in place—where to begin on Monday morning, which audits are low‑hanging fruit, and why focusing only on catching diversion misses the bigger goal of keeping patients and staff safe.
He admits that despite years of preparation, the inspections exposed “blind spots” such as how biennial inventories were documented and who was responsible for reverse distributor shipments until they reached another DEA registrant. The episode doesn’t shy away from the human impact either. If you work in healthcare and suspect your diversion controls are more hope than strategy, this is a candid, practical listen that may change what you prioritise next.
Do you want to link to this podcast?
Get the buttons here!
More From This Show
The latest episodes from the same podcast.